HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes.

Abstract
The failure of pancreatic β cells to adapt to an increasing demand for insulin is the major mechanism by which patients progress from insulin resistance to type 2 diabetes (T2D) and is thought to be related to dysfunctional lipid homeostasis within those cells. In multiple animal models of diabetes, females demonstrate relative protection from β cell failure. We previously found that the hormone 17β-estradiol (E2) in part mediates this benefit. Here, we show that treating male Zucker diabetic fatty (ZDF) rats with E2 suppressed synthesis and accumulation of fatty acids and glycerolipids in islets and protected against β cell failure. The antilipogenic actions of E2 were recapitulated by pharmacological activation of estrogen receptor α (ERα) or ERβ in a rat β cell line and in cultured ZDF rat, mouse, and human islets. Pancreas-specific null deletion of ERα in mice (PERα-/-) prevented reduction of lipid synthesis by E2 via a direct action in islets, and PERα-/- mice were predisposed to islet lipid accumulation and β cell dysfunction in response to feeding with a high-fat diet. ER activation inhibited β cell lipid synthesis by suppressing the expression (and activity) of fatty acid synthase via a nonclassical pathway dependent on activated Stat3. Accordingly, pancreas-specific deletion of Stat3 in mice curtailed ER-mediated suppression of lipid synthesis. These data suggest that extranuclear ERs may be promising therapeutic targets to prevent β cell failure in T2D.
AuthorsJoseph P Tiano, Viviane Delghingaro-Augusto, Cedric Le May, Suhuan Liu, Meenakshi K Kaw, Saja S Khuder, Martin G Latour, Surabhi A Bhatt, Kenneth S Korach, Sonia M Najjar, Marc Prentki, Franck Mauvais-Jarvis
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 121 Issue 8 Pg. 3331-42 (Aug 2011) ISSN: 1558-8238 [Electronic] United States
PMID21747171 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Lipids
  • Receptors, Estrogen
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • Fatty Acid Synthases
Topics
  • Animals
  • Diabetes Mellitus, Type 2 (metabolism)
  • Disease Models, Animal
  • Fatty Acid Synthases (metabolism)
  • Gene Deletion
  • Humans
  • Insulin-Secreting Cells (metabolism)
  • Islets of Langerhans (metabolism)
  • Lipids (chemistry)
  • Male
  • Mice
  • Rats
  • Rats, Zucker
  • Receptors, Estrogen (metabolism)
  • STAT3 Transcription Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: